Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.

Weinblatt ME, Kavanaugh A, Genovese MC, Jones DA, Musser TK, Grossbard EB, Magilavy DB.

J Rheumatol. 2013 Apr;40(4):369-78. doi: 10.3899/jrheum.120923. Epub 2013 Feb 1.

PMID:
23378467
[PubMed - indexed for MEDLINE]
2.

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.

Genovese MC, Kavanaugh A, Weinblatt ME, Peterfy C, DiCarlo J, White ML, O'Brien M, Grossbard EB, Magilavy DB.

Arthritis Rheum. 2011 Feb;63(2):337-45. doi: 10.1002/art.30114.

PMID:
21279990
[PubMed - indexed for MEDLINE]
Free Article
3.

International consensus for a definition of disease flare in lupus.

Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gilkeson G, Ginzler E, Gordon C, Grossman J, Hahn B, Isenberg DA, Kalunian KC, Petri M, Sammaritano L, Sánchez-Guerrero J, Sontheimer RD, Strand V, Urowitz M, von Feldt JM, Werth VP, Merrill JT; Lupus Foundation of America, Inc. International Flare Consensus Initiative.

Lupus. 2011 Apr;20(5):453-62. doi: 10.1177/0961203310388445. Epub 2010 Dec 10.

PMID:
21148601
[PubMed - indexed for MEDLINE]
4.

An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

Weinblatt ME, Kavanaugh A, Genovese MC, Musser TK, Grossbard EB, Magilavy DB.

N Engl J Med. 2010 Sep 30;363(14):1303-12. doi: 10.1056/NEJMoa1000500. Epub 2010 Sep 22.

PMID:
20879879
[PubMed - indexed for MEDLINE]
Free Article
5.

Hylan g-f 20 improves hip osteoarthritis: a prospective, randomized study.

Spitzer AI, Bockow BI, Brander VA, Yates JW, Maccarter DK, Gudger GK, Haller S, Lake SL, Magilavy DB.

Phys Sportsmed. 2010 Jun;38(2):35-47. doi: 10.3810/psm.2010.06.1781.

PMID:
20631462
[PubMed - in process]
6.

Response to: identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20.

Burns JW, Kraines JL, Magilavy DB, Murray CW, Richards SM.

Osteoarthritis Cartilage. 2005 Dec;13(12):1128-9; author reply 1130-1. Epub 2005 Sep 13. No abstract available.

PMID:
16165377
[PubMed - indexed for MEDLINE]
Free Article
7.

Pseudoseptic reactions to Hylan viscosupplementation: diagnosis and treatment.

Magilavy DB, McPherson JM, Polisson R.

Clin Orthop Relat Res. 2004 Dec;(429):349-50; author reply 350-1. No abstract available.

PMID:
15577509
[PubMed - indexed for MEDLINE]
8.

Re: Karlsson et al. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study.

Magilavy D, Polisson R, Parenti D.

Rheumatology (Oxford). 2003 Oct;42(10):1262; author reply 1262-3. No abstract available.

PMID:
14508044
[PubMed - indexed for MEDLINE]
Free Article
9.

Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part I.

Magilavy D, Polisson R, Murray C.

J Bone Joint Surg Am. 2003 Aug;85-A(8):1618-9; author reply 1619-20. No abstract available.

PMID:
12925653
[PubMed - indexed for MEDLINE]
10.

Portal vein thrombosis associated with antiphospholipid antibodies in a child.

Brady L, Magilavy D, Black DD.

J Pediatr Gastroenterol Nutr. 1996 Nov;23(4):470-3. No abstract available.

PMID:
8956190
[PubMed - indexed for MEDLINE]
11.

Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis.

Harel L, Wagner-Weiner L, Poznanski AK, Spencer CH, Ekwo E, Magilavy DB.

Arthritis Rheum. 1993 Oct;36(10):1370-4.

PMID:
8216396
[PubMed - indexed for MEDLINE]
12.

Modulation of murine hepatic lipase activity by exogenous and endogenous Kupffer-cell activation.

Magilavy DB, Zhan R, Black DD.

Biochem J. 1993 May 15;292 ( Pt 1):249-52.

PMID:
8503853
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Liver of MRL/lpr mice contain interleukin-4-producing lymphocytes and accessory cells that support the proliferation of Th2 helper T lymphocyte clones.

Magilavy DB, Foys KM, Gajewski TF.

Eur J Immunol. 1992 Sep;22(9):2359-65.

PMID:
1387611
[PubMed - indexed for MEDLINE]
14.

Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis.

Lipnick RN, Tsokos GC, Magilavy DB.

Rheum Dis Clin North Am. 1991 Nov;17(4):843-57. Review.

PMID:
1767077
[PubMed - indexed for MEDLINE]
15.

Animal models of chronic inflammatory arthritis.

Magilavy DB.

Clin Orthop Relat Res. 1990 Oct;(259):38-45. Review.

PMID:
2208871
[PubMed - indexed for MEDLINE]
16.

The liver of MRL/lpr mice contains defective accessory cells and a population of immunosuppressive lymphocytes.

Magilavy DB, Rowley DA, Davis M.

Cell Immunol. 1990 Feb;125(2):469-79.

PMID:
2137036
[PubMed - indexed for MEDLINE]
17.

Pediatric rheumatology manpower and training: planning for the 1990s.

Lehman TJ, Magilavy DB, Warren R.

Pediatrics. 1989 Sep;84(3):567-8. No abstract available.

PMID:
2771557
[PubMed - indexed for MEDLINE]
18.

Murine hepatic accessory cells support the proliferation of Th1 but not Th2 helper T lymphocyte clones.

Magilavy DB, Fitch FW, Gajewski TF.

J Exp Med. 1989 Sep 1;170(3):985-90.

PMID:
2527946
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

Lehman TJ, Sherry DD, Wagner-Weiner L, McCurdy DK, Emery HM, Magilavy DB, Kovalesky A.

J Pediatr. 1989 Jun;114(6):1055-60.

PMID:
2656961
[PubMed - indexed for MEDLINE]
20.

A comparison of murine hepatic accessory cells and splenic dendritic cells.

Shah PD, Rowley DA, Latta SL, Magilavy DB.

Cell Immunol. 1989 Feb;118(2):394-405.

PMID:
2521309
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk